BUZZ-Xilio股价因意外季度盈利而上涨

路透中文
Mar 23
BUZZ-Xilio股价因意外季度盈利而上涨

3月23日 - ** 药物开发商Xilio Therapeutics XLO.O股价盘前上涨3.18%至8.11美元

** 该公司公布第四季度每股利润为81美分,而分析师此前预期为每股亏损1.68美元,数据由LSEG编制 (link)

** 该公司第四季度营收为1,370万美元,高于预期的790万美元。

** 称由于艾伯维(AbbVie)合作和吉利德(Gilead)许可协议的推动,合作和许可收入增加,导致季度收入增长

** 2025 年,XLO 股价下跌超过 32%

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10